Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
54,462,831
-
Share change
-
+221,410
-
Total reported value
-
$1,921,442,064
-
Price per share
-
$35.28
-
Number of holders
-
172
-
Value change
-
+$18,983,073
-
Number of buys
-
82
-
Number of sells
-
101
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2014
As of 30 Jun 2014,
HAEMONETICS CORP - Common Stock (HAE) was held by
172 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,462,831 shares.
The largest 10 holders included
Neuberger Berman Group LLC, VANGUARD GROUP INC, BARROW HANLEY MEWHINNEY & STRAUSS LLC, BlackRock Fund Advisors, FMR LLC, WELLINGTON MANAGEMENT CO LLP, BlackRock Institutional Trust Company, N.A., WESTWOOD HOLDINGS GROUP INC, Van Berkom & Associates Inc., and PRUDENTIAL PLC.
This page lists
172
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.